REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | Return to index | ||||||||
Order | Gene | Description | ref_hepatocyte | HepG2 | HepG2.C3A | HuH.7 | SNU475 | THLE | liver |
1 | ACTB | Actin, cytoplasmic 1 | [1] | -0.77[2] | -0.99[3] | -0.44[4] | -0.41[5] | -0.56[6] | -0.03[7] |
2 | ACTG1 | Actin, cytoplasmic 2 | [8] | 0.51[9] | -0.35[10] | -0.33[11] | -0.61[12] | 0.02[13] | -0.78[14] |
3 | CFL1 | Cofilin-1 | [15] | 0.36[16] | -0.20[17] | -0.30[18] | 0.11[19] | 0.41[20] | 0.21[21] |
4 | RHOA | Transforming protein RhoA | [22] | -0.32[23] | -0.35[24] | -0.21[25] | -0.64[26] | 0.04[27] | -0.17[28] |
5 | ARPC3 | Actin-related protein 2/3 complex subunit 3 | [29] | -0.90[30] | 0.07[31] | -0.50[32] | -0.84[33] | -0.92[34] | -1.34[35] |
6 | CDC42 | Cell division control protein 42 homolog | [36] | -0.21[37] | 0.98[38] | -0.11[39] | 0.05[40] | -0.44[41] | -0.93[42] |
7 | ARPC2 | Actin-related protein 2/3 complex subunit 2 | [43] | 0.24[44] | 0.49[45] | -0.09[46] | 0.21[47] | 0.36[48] | -0.62[49] |
8 | ACTR2 | Actin-related protein 2 | [50] | 0.56[51] | 1.22[52] | 1.04[53] | 1.43[54] | 1.07[55] | -0.15[56] |
9 | ACTR3 | Actin-related protein 3 | [57] | 0.33[58] | 0.98[59] | 0.34[60] | 1.43[61] | 0.72[62] | 0.22[63] |
10 | RAC1 | Ras-related C3 botulinum toxin substrate 1 | [64] | 0.23[65] | 0.36[66] | 0.99[67] | 0.59[68] | 0.81[69] | 0.19[70] |
11 | ARPC5 | Actin-related protein 2/3 complex subunit 5 | [71] | 0.20[72] | 0.02[73] | -0.69[74] | 1.47[75] | 0.88[76] | 0.21[77] |
12 | SDC2 | Syndecan-2 | [78] | 1.03[79] | 2.44[80] | 2.00[81] | 0.39[82] | -2.59[83] | 1.78[84] |
13 | ARPC1A | Actin-related protein 2/3 complex subunit 1A | [85] | 0.03[86] | 0.01[87] | 0.65[88] | 0.27[89] | 0.18[90] | 0.26[91] |
14 | ARPC4 | Actin-related protein 2/3 complex subunit 4 | [92] | -0.79[93] | -0.83[94] | 0.67[95] | -0.90[96] | -0.37[97] | -0.75[98] |
15 | ARPC1B | Actin-related protein 2/3 complex subunit 1B | [99] | 0.61[100] | 0.77[101] | -0.29[102] | 1.53[103] | 0.79[104] | 0.17[105] |
16 | YES1 | Tyrosine-protein kinase Yes | [106] | -0.24[107] | 1.71[108] | 1.86[109] | 1.03[110] | 0.73[111] | 1.28[112] |
17 | HRAS | GTPase HRas | [113] | -0.39[114] | -0.63[115] | -1.50[116] | -0.37[117] | -0.35[118] | -1.51[119] |
18 | PTK2 | Focal adhesion kinase 1 | [120] | 1.36[121] | 2.31[122] | 2.61[123] | 2.53[124] | 1.96[125] | 1.92[126] |
19 | ITSN1 | Intersectin-1 | [127] | 0.51[128] | 1.09[129] | 1.77[130] | 1.59[131] | 2.08[132] | 2.88[133] |
20 | WASL | Neural Wiskott-Aldrich syndrome protein | [134] | 0.14[135] | 1.68[136] | 2.00[137] | 1.68[138] | 1.07[139] | 2.29[140] |
21 | EPHB4 | Ephrin type-B receptor 4 | [141] | 2.54[142] | 2.38[143] | 2.56[144] | 0.01[145] | 1.03[146] | 2.84[147] |
22 | ROCK1 | Rho-associated protein kinase 1 | [148] | -0.33[149] | 1.66[150] | 2.35[151] | 1.94[152] | 1.52[153] | 2.74[154] |
23 | LYN | Tyrosine-protein kinase Lyn | [155] | -0.24[156] | 0.05[157] | 0.50[158] | 1.64[159] | 0.63[160] | 1.17[161] |
24 | ROCK2 | Rho-associated protein kinase 2 | [162] | 2.09[163] | 3.80[164] | 2.19[165] | 3.22[166] | 1.22[167] | 3.08[168] |
25 | SRC | Proto-oncogene tyrosine-protein kinase Src | [169] | 3.64[170] | 4.10[171] | 3.01[172] | 2.98[173] | 2.39[174] | 0.31[175] |
26 | LIMK2 | LIM domain kinase 2 | [176] | 2.12[177] | 2.96[178] | 3.03[179] | 0.95[180] | 1.82[181] | 2.44[182] |
27 | RASA1 | Ras GTPase-activating protein 1 | [183] | 1.00[184] | 2.38[185] | 2.40[186] | 2.50[187] | 1.78[188] | 2.37[189] |
28 | LIMK1 | LIM domain kinase 1 | [190] | 2.92[191] | 2.28[192] | 1.78[193] | 4.09[194] | 2.56[195] | -0.33[196] |
29 | PAK1 | Serine/threonine-protein kinase PAK 1 | [197] | 0.61[198] | 0.32[199] | 2.64[200] | -1.28[201] | 2.74[202] | 1.42[203] |
30 | FYN | Tyrosine-protein kinase Fyn | [204] | 1.56[205] | -6.57[206] | 1.91[207] | 2.05[208] | 3.81[209] | 2.13[210] |
31 | EFNB1 | Ephrin-B1 | [211] | 1.96[212] | 0.42[213] | -6.74[214] | 2.19[215] | 2.50[216] | 2.07[217] |
32 | KALRN | Kalirin | [218] | 1.96[219] | 3.98[220] | 3.39[221] | 2.49[222] | -1.94[223] | 4.72[224] |
33 | EPHB2 | Ephrin type-B receptor 2 | [225] | -0.21[226] | -4.81[227] | 1.54[228] | 2.95[229] | 3.93[230] | -0.42[231] |
34 | EPHB6 | Ephrin type-B receptor 6 | [232] | -4.49[233] | [234] | -7.03[235] | -2.11[236] | 1.11[237] | 1.95[238] |
35 | TIAM1 | T-lymphoma invasion and metastasis-inducing protein 1 | [239] | -4.08[240] | -0.94[241] | -6.21[242] | -0.78[243] | 1.50[244] | 4.50[245] |
36 | EPHB1 | Ephrin type-B receptor 1 | [246] | 1.40[247] | -3.82[248] | -4.77[249] | [250] | -4.80[251] | 2.92[252] |
37 | EFNB2 | Ephrin-B2 | [253] | 0.04[254] | -1.67[255] | 1.18[256] | -0.33[257] | 5.91[258] | 4.98[259] |
38 | EPHB3 | Ephrin type-B receptor 3 | [260] | 1.22[261] | -2.84[262] | 4.37[263] | 3.95[264] | 4.05[265] | 4.16[266] |
39 | GRIN2B | Glutamate receptor ionotropic, NMDA 2B | [267] | -1.84[268] | [269] | [270] | 1.67[271] | -0.91[272] | 3.02[273] |
40 | EFNB3 | Ephrin-B3 | [274] | 3.65[275] | 0.58[276] | 2.11[277] | 4.31[278] | 6.84[279] | 4.82[280] |
41 | ARHGEF28 | Rho guanine nucleotide exchange factor 28 | [281] | [282] | [283] | [284] | [285] | [286] | [287] |
42 | GRIN1 | Glutamate receptor ionotropic, NMDA 1 | [288] | [289] | [290] | [291] | [292] | [293] | [294] |